A leader in the field of individual gene therapy.

In a previous study, AMT’s gene treatment approach was been shown to be effective in the treatment of diseased human muscles cells attained from biopsies of DMD individuals. These data establish a robust basis for AMT’s therapeutic method of DMD. ‘In particular, our positive results in the center and respiratory muscle tissues bring hope that we could probably avoid the fatal outcome of this disease in the future, potentially through a long-term remedy with a single treatment.’.. AMT’s gene therapy successful in treating Duchenne muscular dystrophy Amsterdam Molecular Therapeutics , a leader in the field of individual gene therapy, announced today that it has successfully treated Duchenne muscular dystrophy in an animal model with its proprietary gene therapy.Related StoriesViralytics enters into scientific trial collaboration contract with MSDNew findings reveal association between colorectal cancer tumor and melanoma drug treatmentOvarian cancer sufferers with a history of oral contraceptive use have better outcomesTaken collectively, Antonarakis says, the findings, if confirmed in bigger trials, suggest that the presence of the AR-V7 variant could be used someday as a biomarker to boost treatment decision-making for patients with prostate cancer.